PharmacoEconomics via MedWorm.com MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'PharmacoEconomics' source. Sat, 20 Mar 2010 15:50:48 +0100 Towards More Consistent Use of Generic Quality-of-Life Instruments http://www.medworm.com/index.php?rid=3361734&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2010%2F00000028%2F00000004%2Fart00006 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=3361734 Sat, 13 Mar 2010 15:50:45 +0100 3361734 Cost Effectiveness of Etoricoxib versus Celecoxib and Non-Selective NSAIDS in the Treatment of Ankylosing Spondylitis http://www.medworm.com/index.php?rid=3361733&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2010%2F00000028%2F00000004%2Fart00005 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=3361733 Sat, 13 Mar 2010 15:50:45 +0100 3361733 Pharmacoeconomic Evaluation in Ireland: A Review of the Process http://www.medworm.com/index.php?rid=3361732&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2010%2F00000028%2F00000004%2Fart00004 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=3361732 Sat, 13 Mar 2010 15:50:45 +0100 3361732 Does the Funding Source Influence the Results in Economic Evaluations?: A Case Study in Bisphosphonates for the Treatment of Osteoporosis http://www.medworm.com/index.php?rid=3361731&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2010%2F00000028%2F00000004%2Fart00003 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=3361731 Sat, 13 Mar 2010 15:50:45 +0100 3361731 Cost Effectiveness of Respiratory Syncytial Virus Prophylaxis: A Critical and Systematic Review http://www.medworm.com/index.php?rid=3361730&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2010%2F00000028%2F00000004%2Fart00002 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=3361730 Sat, 13 Mar 2010 15:50:45 +0100 3361730 A Review of Methods Used in Long-Term Cost-Effectiveness Models of Diabetes Mellitus Treatment http://www.medworm.com/index.php?rid=3361729&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2010%2F00000028%2F00000004%2Fart00001 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=3361729 Sat, 13 Mar 2010 02:06:26 +0100 3361729 Varenicline: A Pharmacoeconomic Review of its Use as an Aid to Smoking Cessation http://www.medworm.com/index.php?rid=3278944&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2010%2F00000028%2F00000003%2Fart00006 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=3278944 Wed, 17 Feb 2010 16:08:55 +0100 3278944 Cost Effectiveness of High-Dose Intravenous Esomeprazole for Peptic Ulcer Bleeding http://www.medworm.com/index.php?rid=3278943&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2010%2F00000028%2F00000003%2Fart00005 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=3278943 Wed, 17 Feb 2010 16:08:55 +0100 3278943 Estimation of a Valuation Function for a Diabetes Mellitus-Specific Preference-Based Measure of Health: The Diabetes Utility Index http://www.medworm.com/index.php?rid=3278942&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2010%2F00000028%2F00000003%2Fart00004 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=3278942 Wed, 17 Feb 2010 16:08:55 +0100 3278942 The Cost Effectiveness of Rufinamide in the Treatment of Lennox-Gastaut Syndrome in the UK http://www.medworm.com/index.php?rid=3278941&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2010%2F00000028%2F00000003%2Fart00003 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=3278941 Wed, 17 Feb 2010 16:08:55 +0100 3278941 Healthcare Rationing by Proxy: Cost-Effectiveness Analysis and the Misuse of the 50000 Threshold in the US http://www.medworm.com/index.php?rid=3278940&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2010%2F00000028%2F00000003%2Fart00002 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=3278940 Wed, 17 Feb 2010 16:08:55 +0100 3278940 Measuring Quality of Life for Certain Events versus Pre-Specified Points in Time http://www.medworm.com/index.php?rid=3278939&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2010%2F00000028%2F00000003%2Fart00001 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=3278939 Wed, 17 Feb 2010 02:06:01 +0100 3278939 Access with Evidence Development in the UK: Past Experience, Current Initiatives and Future Potential http://www.medworm.com/index.php?rid=3199756&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2010%2F00000028%2F00000002%2Fart00007 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=3199756 Sat, 23 Jan 2010 15:34:28 +0100 3199756 Access with Evidence Development: The US Experience http://www.medworm.com/index.php?rid=3199755&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2010%2F00000028%2F00000002%2Fart00006 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=3199755 Sat, 23 Jan 2010 15:34:28 +0100 3199755 Access with Evidence Development Schemes: A Framework for Description and Evaluation http://www.medworm.com/index.php?rid=3199754&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2010%2F00000028%2F00000002%2Fart00005 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=3199754 Sat, 23 Jan 2010 15:34:28 +0100 3199754 Funding the Unfundable: Mechanisms for Managing Uncertainty in Decisions on the Introduction of New and Innovative Technologies into Healthcare Systems http://www.medworm.com/index.php?rid=3199753&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2010%2F00000028%2F00000002%2Fart00004 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=3199753 Sat, 23 Jan 2010 15:34:28 +0100 3199753 Principles of Design of Access with Evidence Development Approaches: A Consensus Statement from the Banff Summit http://www.medworm.com/index.php?rid=3199752&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2010%2F00000028%2F00000002%2Fart00003 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=3199752 Sat, 23 Jan 2010 15:34:28 +0100 3199752 We Know Accurately Only When We Know Little http://www.medworm.com/index.php?rid=3199751&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2010%2F00000028%2F00000002%2Fart00002 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=3199751 Sat, 23 Jan 2010 15:34:28 +0100 3199751 Cant Get No Satisfaction? Will Pay for Performance Help?: Toward an Economic Framework for Understanding Performance-Based Risk-Sharing Agreements for Innovative Medical Products http://www.medworm.com/index.php?rid=3199750&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2010%2F00000028%2F00000002%2Fart00001 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=3199750 Sat, 23 Jan 2010 02:06:16 +0100 3199750 Erlotinib: A Pharmacoeconomic Review of its Use in Advanced Non-Small Cell Lung Cancer http://www.medworm.com/index.php?rid=3103843&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2010%2F00000028%2F00000001%2Fart00007 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=3103843 Sat, 19 Dec 2009 15:34:44 +0100 3103843 A Policy Model to Evaluate the Benefits, Risks and Costs of Warfarin Pharmacogenomic Testing http://www.medworm.com/index.php?rid=3103842&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2010%2F00000028%2F00000001%2Fart00006 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=3103842 Sat, 19 Dec 2009 15:34:44 +0100 3103842 Cost Effectiveness of Intensive Lipid-Lowering Treatment for Patients with Congestive Heart Failure and Coronary Heart Disease in the US http://www.medworm.com/index.php?rid=3103841&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2010%2F00000028%2F00000001%2Fart00005 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=3103841 Sat, 19 Dec 2009 15:34:44 +0100 3103841 Cost Effectiveness of Rituximab Maintenance Therapy in Follicular Lymphoma: Long-Term Economic Evaluation http://www.medworm.com/index.php?rid=3103840&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2010%2F00000028%2F00000001%2Fart00004 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=3103840 Sat, 19 Dec 2009 15:34:44 +0100 3103840 The Cost and Incidence of Prescribing Errors Among Privately Insured HIV Patients http://www.medworm.com/index.php?rid=3103839&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2010%2F00000028%2F00000001%2Fart00003 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=3103839 Sat, 19 Dec 2009 15:34:44 +0100 3103839 Adverse Drug Interactions: Moving from Perception to Action http://www.medworm.com/index.php?rid=3103838&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2010%2F00000028%2F00000001%2Fart00002 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=3103838 Sat, 19 Dec 2009 15:34:44 +0100 3103838 Should Financial Incentives be Used to Differentially Reward Me-Too and Innovative Drugs? http://www.medworm.com/index.php?rid=3103837&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2010%2F00000028%2F00000001%2Fart00001 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=3103837 Sat, 19 Dec 2009 02:07:36 +0100 3103837 Accounting for the Development of Antibacterial Resistance in the Cost Effectiveness of Ertapenem versus PiperacillinTazobactam in the Treatment of Diabetic Foot Infections in the UK http://www.medworm.com/index.php?rid=2995038&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000012%2Fart00008 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2995038 Mon, 16 Nov 2009 15:59:40 +0100 2995038 Healthcare Costs and Obesity Prevention: Drug Costs and Other Sector-Specific Consequences http://www.medworm.com/index.php?rid=2995037&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000012%2Fart00007 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2995037 Mon, 16 Nov 2009 15:59:40 +0100 2995037 Bayesian Modelling of Healthcare Resource Use in Multinational Randomized Clinical Trials http://www.medworm.com/index.php?rid=2995036&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000012%2Fart00006 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2995036 Mon, 16 Nov 2009 15:59:40 +0100 2995036 Willingness to Pay for a QALY Based on Community Member and Patient Preferences for Temporary Health States Associated with Herpes Zoster http://www.medworm.com/index.php?rid=2995035&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000012%2Fart00005 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2995035 Mon, 16 Nov 2009 15:59:40 +0100 2995035 Cost Effectiveness of Herpes Zoster Vaccine in Canada http://www.medworm.com/index.php?rid=2995034&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000012%2Fart00004 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2995034 Mon, 16 Nov 2009 15:59:40 +0100 2995034 Weighting Must Wait: Incorporating Equity Concerns into Cost-Effectiveness Analysis May Take Longer than Expected http://www.medworm.com/index.php?rid=2995033&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000012%2Fart00003 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2995033 Mon, 16 Nov 2009 15:59:40 +0100 2995033 Swimming Upstream: Comparative Effectiveness Research in the US http://www.medworm.com/index.php?rid=2995032&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000012%2Fart00002 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2995032 Mon, 16 Nov 2009 15:59:40 +0100 2995032 Acknowledgment http://www.medworm.com/index.php?rid=2995031&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000012%2Fart00001 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2995031 Mon, 16 Nov 2009 02:08:26 +0100 2995031 Cost Effectiveness of Facility-Based Care, Home-Based Care and Mobile Clinics for Provision of Antiretroviral Therapy in Uganda http://www.medworm.com/index.php?rid=2980045&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000011%2Fart00007 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2980045 Wed, 11 Nov 2009 15:54:49 +0100 2980045 Information Technology Facilitates Cost-Effectiveness Analysis in Developing Countries: An Observational Study of Breast Cancer Chemotherapy in Taiwan http://www.medworm.com/index.php?rid=2980044&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000011%2Fart00006 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2980044 Wed, 11 Nov 2009 15:54:49 +0100 2980044 Strengthening Cost-Effectiveness Analysis in Thailand through the Establishment of the Health Intervention and Technology Assessment Program http://www.medworm.com/index.php?rid=2980043&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000011%2Fart00005 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2980043 Wed, 11 Nov 2009 15:54:49 +0100 2980043 Barriers to Generalizability of Health Economic Evaluations in Latin America and the Caribbean Region http://www.medworm.com/index.php?rid=2980042&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000011%2Fart00004 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2980042 Wed, 11 Nov 2009 15:54:49 +0100 2980042 Cost Effectiveness in Low- and Middle-Income Countries: A Review of the Debates Surrounding Decision Rules http://www.medworm.com/index.php?rid=2980041&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000011%2Fart00003 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2980041 Wed, 11 Nov 2009 15:54:49 +0100 2980041 The Future of Health Technology Assessment in Healthcare Decision Making in Asia http://www.medworm.com/index.php?rid=2980040&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000011%2Fart00002 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2980040 Wed, 11 Nov 2009 15:54:49 +0100 2980040 Developing Nations Special Issue http://www.medworm.com/index.php?rid=2980039&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000011%2Fart00001 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2980039 Wed, 11 Nov 2009 02:06:57 +0100 2980039 Cost-Effectiveness Analysis of Adjuvant Therapy for Operable Breast Cancer from a Chinese Perspective: Doxorubicin plus Cyclophosphamide versus Docetaxel plus Cyclophosphamide http://www.medworm.com/index.php?rid=2882339&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000010%2Fart00007 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2882339 Mon, 12 Oct 2009 14:33:38 +0100 2882339 30 Years of Pharmaceutical Cost-Utility Analyses: Growth, Diversity and Methodological Improvement http://www.medworm.com/index.php?rid=2882338&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000010%2Fart00006 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2882338 Mon, 12 Oct 2009 14:33:38 +0100 2882338 An Economic Evaluation of Docetaxel and Paclitaxel Regimens in Metastatic Breast Cancer in the UK http://www.medworm.com/index.php?rid=2882337&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000010%2Fart00005 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2882337 Mon, 12 Oct 2009 14:33:38 +0100 2882337 A Cost-Effectiveness Model Comparing Rivaroxaban and Dabigatran Etexilate with Enoxaparin Sodium as Thromboprophylaxis after Total Hip and Total Knee Replacement in the Irish Healthcare Setting http://www.medworm.com/index.php?rid=2882336&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000010%2Fart00004 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2882336 Mon, 12 Oct 2009 14:33:38 +0100 2882336 Budget-Impact Analyses: A Critical Review of Published Studies http://www.medworm.com/index.php?rid=2882335&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000010%2Fart00003 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2882335 Mon, 12 Oct 2009 14:33:38 +0100 2882335 Economic Evaluation and Cost-Effectiveness Thresholds: Signals to Firms and Implications for RD Investment and Innovation http://www.medworm.com/index.php?rid=2882334&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000010%2Fart00002 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2882334 Mon, 12 Oct 2009 14:33:38 +0100 2882334 New Anticoagulants for the Prevention of Deep Venous Thrombosis: Time to Consider Cost Effectiveness? http://www.medworm.com/index.php?rid=2882333&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000010%2Fart00001 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2882333 Mon, 12 Oct 2009 02:06:25 +0100 2882333 Incremental 1-Year Medical Resource Utilization and Costs for Patients with Herpes Zoster from a Set of US Health Plans http://www.medworm.com/index.php?rid=2806589&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000009%2Fart00008 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2806589 Fri, 18 Sep 2009 17:31:40 +0100 2806589 Utilities of the EQ-5D: Transferable or Not? http://www.medworm.com/index.php?rid=2806588&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000009%2Fart00007 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2806588 Fri, 18 Sep 2009 17:31:40 +0100 2806588 The Importance of Clinical Variables in Comparative Analyses Using Propensity-Score Matching: The Case of ESA Costs for the Treatment of Chemotherapy-Induced Anaemia http://www.medworm.com/index.php?rid=2806587&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000009%2Fart00006 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2806587 Fri, 18 Sep 2009 17:31:40 +0100 2806587 Comparing Three Software Tools for Implementing Markov Models for Health Economic Evaluations http://www.medworm.com/index.php?rid=2806586&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000009%2Fart00005 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2806586 Fri, 18 Sep 2009 17:31:40 +0100 2806586 A Cost-Effectiveness Analysis to Illustrate the Impact of Cost Definitions on Results, Interpretations and Comparability of Pharmacoeconomic Studies in the US http://www.medworm.com/index.php?rid=2806585&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000009%2Fart00004 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2806585 Fri, 18 Sep 2009 17:31:40 +0100 2806585 Head Lice Treatments and School Policies in the US in an Era of Emerging Resistance: A Cost-Effectiveness Analysis http://www.medworm.com/index.php?rid=2806584&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000009%2Fart00003 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2806584 Fri, 18 Sep 2009 17:31:40 +0100 2806584 Methods for Measuring Temporary Health States for Cost-Utility Analyses http://www.medworm.com/index.php?rid=2806583&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000009%2Fart00002 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2806583 Fri, 18 Sep 2009 17:31:40 +0100 2806583 The Role of Patient Preferences in Cost-Effectiveness Analysis: A Conflict of Values? http://www.medworm.com/index.php?rid=2806582&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000009%2Fart00001 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2806582 Fri, 18 Sep 2009 02:06:15 +0100 2806582 Determinants of Willingness to Pay for a New Therapy in a Sample of Menopausal-Aged Women http://www.medworm.com/index.php?rid=2747316&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000008%2Fart00007 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2747316 Mon, 31 Aug 2009 13:20:45 +0100 2747316 The Cost of Disability and Medically Related Absenteeism Among Employees with Multiple Sclerosis in the US http://www.medworm.com/index.php?rid=2747315&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000008%2Fart00006 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2747315 Mon, 31 Aug 2009 13:20:45 +0100 2747315 Economic Burden of Follicular Non-Hodgkins Lymphoma http://www.medworm.com/index.php?rid=2747314&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000008%2Fart00005 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2747314 Mon, 31 Aug 2009 13:20:45 +0100 2747314 A Decision-Theoretic Framework for the Application of Cost-Effectiveness Analysis in Regulatory Processes http://www.medworm.com/index.php?rid=2747313&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000008%2Fart00004 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2747313 Mon, 31 Aug 2009 13:20:45 +0100 2747313 Estimating Drug Costs in Economic Evaluations in Ireland and the UK: An Analysis of Practice and Research Recommendations http://www.medworm.com/index.php?rid=2747312&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000008%2Fart00003 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2747312 Mon, 31 Aug 2009 13:20:45 +0100 2747312 Case-Control Studies in Pharmacoeconomic Research: An Overview http://www.medworm.com/index.php?rid=2747311&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000008%2Fart00002 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2747311 Mon, 31 Aug 2009 13:20:45 +0100 2747311 Legal and Economic Perspectives Concerning US Government Investigations of Alleged Off-Label Promotion by Drug Manufacturers http://www.medworm.com/index.php?rid=2747310&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000008%2Fart00001 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2747310 Mon, 31 Aug 2009 02:07:31 +0100 2747310 Cost Utility of Adalimumab versus Infliximab Maintenance Therapies in the United States for Moderately to Severely Active Crohns Disease http://www.medworm.com/index.php?rid=2687467&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000007%2Fart00008 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2687467 Tue, 11 Aug 2009 11:47:24 +0100 2687467 Cost-Effectiveness Analysis of Capecitabine Compared with Bolus 5-Fluorouracill-Leucovorin for the Adjuvant Treatment of Colon Cancer in Japan http://www.medworm.com/index.php?rid=2687466&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000007%2Fart00007 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2687466 Tue, 11 Aug 2009 11:47:24 +0100 2687466 Cost Effectiveness of Fondaparinux in Non-ST-Elevation Acute Coronary Syndrome http://www.medworm.com/index.php?rid=2687465&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000007%2Fart00006 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2687465 Tue, 11 Aug 2009 11:47:24 +0100 2687465 Costs of Illness in a Russian Cohort of Patients with Parkinsons Disease http://www.medworm.com/index.php?rid=2687464&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000007%2Fart00005 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2687464 Tue, 11 Aug 2009 11:47:24 +0100 2687464 Economic Evaluations in the EURONHEED: A Comparative Analysis http://www.medworm.com/index.php?rid=2687463&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000007%2Fart00004 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2687463 Tue, 11 Aug 2009 11:47:24 +0100 2687463 Societal and Patient Burden of Fibromyalgia Syndrome http://www.medworm.com/index.php?rid=2687462&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000007%2Fart00003 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2687462 Tue, 11 Aug 2009 11:47:24 +0100 2687462 Calibration Methods Used in Cancer Simulation Models and Suggested Reporting Guidelines http://www.medworm.com/index.php?rid=2687461&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000007%2Fart00002 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2687461 Tue, 11 Aug 2009 11:47:24 +0100 2687461 Is it Time for Reporting Guidelines for Calibration Methods? http://www.medworm.com/index.php?rid=2687460&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000007%2Fart00001 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2687460 Tue, 11 Aug 2009 02:06:51 +0100 2687460 How to Deal with Cost Differences at Baseline http://www.medworm.com/index.php?rid=2662246&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000006%2Fart00007 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2662246 Sun, 02 Aug 2009 11:54:31 +0100 2662246 Determinants of Direct Cost Differences among US Employees with Major Depressive Disorders Using Antidepressants http://www.medworm.com/index.php?rid=2662245&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000006%2Fart00006 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2662245 Sun, 02 Aug 2009 11:54:31 +0100 2662245 Converting the SF-12 into the EQ-5D: An Empirical Comparison of Methodologies http://www.medworm.com/index.php?rid=2662244&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000006%2Fart00005 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2662244 Sun, 02 Aug 2009 11:54:31 +0100 2662244 Economic Outcomes Associated with Microvascular Complications of Type 2 Diabetes Mellitus: Results from a US Claims Data Analysis http://www.medworm.com/index.php?rid=2662243&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000006%2Fart00004 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2662243 Sun, 02 Aug 2009 11:54:31 +0100 2662243 Holistic Preferences for 1-Year Health Profiles Describing Fluctuations in Health: The Case of Chronic Obstructive Pulmonary Disease http://www.medworm.com/index.php?rid=2662242&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000006%2Fart00003 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2662242 Sun, 02 Aug 2009 11:54:31 +0100 2662242 Pharmacoeconomic Considerations in Treating Actinic Keratosis http://www.medworm.com/index.php?rid=2662241&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000006%2Fart00002 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2662241 Sun, 02 Aug 2009 11:54:31 +0100 2662241 Cost Effectiveness of Influenza Vaccination in Older Adults: A Critical Review of Economic Evaluations for the 50- to 64-Year Age Group http://www.medworm.com/index.php?rid=2662240&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000006%2Fart00001 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2662240 Sun, 02 Aug 2009 02:06:32 +0100 2662240 Update of Recent Reforms in Germany to Enhance the Quality and Efficiency of Prescribing of Proton Pump Inhibitors and Lipid-Lowering Drugs http://www.medworm.com/index.php?rid=2590503&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000005%2Fart00010 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2590503 Sat, 11 Jul 2009 11:48:42 +0100 2590503 The Authors Reply http://www.medworm.com/index.php?rid=2590502&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000005%2Fart00009 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2590502 Sat, 11 Jul 2009 11:48:42 +0100 2590502 Cost-Effectiveness Evaluation of a Quadrivalent Human Papillomavirus Vaccine in Belgium http://www.medworm.com/index.php?rid=2590501&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000005%2Fart00008 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2590501 Sat, 11 Jul 2009 11:48:42 +0100 2590501 Pharmaceutical Risk-Sharing Agreements http://www.medworm.com/index.php?rid=2590500&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000005%2Fart00007 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2590500 Sat, 11 Jul 2009 11:48:42 +0100 2590500 Outcomes Associated with Initial versus Later Vancomycin Use in Patients with Complicated Skin and Skin-Structure Infections http://www.medworm.com/index.php?rid=2590499&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000005%2Fart00006 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2590499 Sat, 11 Jul 2009 11:48:42 +0100 2590499 Utility Assessment in Patients with Mental Disorders: Validity and Discriminative Ability of the Time Trade-Off Method http://www.medworm.com/index.php?rid=2590498&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000005%2Fart00005 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2590498 Sat, 11 Jul 2009 11:48:42 +0100 2590498 The Cost of Dementia in Europe: A Review of the Evidence, and Methodological Considerations http://www.medworm.com/index.php?rid=2590497&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000005%2Fart00004 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2590497 Sat, 11 Jul 2009 11:48:42 +0100 2590497 Costing Infectious Disease Outbreaks for Economic Evaluation: A Review for Hepatitis A http://www.medworm.com/index.php?rid=2590496&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000005%2Fart00003 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2590496 Sat, 11 Jul 2009 11:48:42 +0100 2590496 The Cost and Impact of Health Conditions on Presenteeism to Employers: A Review of the Literature http://www.medworm.com/index.php?rid=2590495&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000005%2Fart00002 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2590495 Sat, 11 Jul 2009 11:48:42 +0100 2590495 The Future Costs, Risks and Rewards of Drug Development: The Economics of Pharmacogenomics http://www.medworm.com/index.php?rid=2590494&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000005%2Fart00001 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2590494 Sat, 11 Jul 2009 02:07:23 +0100 2590494 Update of Recent Reforms in Germany to Enhance the Quality and Efficiency of Prescribing of Proton Pump Inhibitors and Lipid-Lowering Drugs. http://www.medworm.com/index.php?rid=2587227&cid=s_33940_51_f&fid=34367&url=http%3A%2F%2Fpharmacoeconomics.adisonline.com%2Fpt%2Fre%2Fphe%2Fabstract.00019053-200927050-00010.htm Page: 435DOI: 10.2165/00019053-200927050-00010Authors: Godman, Brian 1 2; Schwabe, Ulrich 3; Selke, Gisbert 4; Wettermark, Bjorn 5 6 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2587227 Fri, 10 Jul 2009 11:58:01 +0100 2587227 The Author's Reply. http://www.medworm.com/index.php?rid=2587226&cid=s_33940_51_f&fid=34367&url=http%3A%2F%2Fpharmacoeconomics.adisonline.com%2Fpt%2Fre%2Fphe%2Fabstract.00019053-200927050-00009.htm Page: 433DOI: 10.2165/00019053-200927050-00009Authors: Lieven Annemans, on behalf of the authors (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2587226 Fri, 10 Jul 2009 11:58:01 +0100 2587226 Cost-Effectiveness Evaluation of a Quadrivalent Human Papillomavirus Vaccine in Belgium. http://www.medworm.com/index.php?rid=2587225&cid=s_33940_51_f&fid=34367&url=http%3A%2F%2Fpharmacoeconomics.adisonline.com%2Fpt%2Fre%2Fphe%2Fabstract.00019053-200927050-00008.htm Page: 433DOI: 10.2165/00019053-200927050-00008Authors: Cleemput, Irina; Thiry, Nancy (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2587225 Fri, 10 Jul 2009 11:58:01 +0100 2587225 Pharmaceutical Risk-Sharing Agreements. http://www.medworm.com/index.php?rid=2587224&cid=s_33940_51_f&fid=34367&url=http%3A%2F%2Fpharmacoeconomics.adisonline.com%2Fpt%2Fre%2Fphe%2Fabstract.00019053-200927050-00007.htm Page: 431DOI: 10.2165/00019053-200927050-00007Authors: Gandjour, Afschin (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2587224 Fri, 10 Jul 2009 11:58:01 +0100 2587224 Outcomes Associated with Initial versus Later Vancomycin Use in Patients with Complicated Skin and Skin-Structure Infections. http://www.medworm.com/index.php?rid=2587223&cid=s_33940_51_f&fid=34367&url=http%3A%2F%2Fpharmacoeconomics.adisonline.com%2Fpt%2Fre%2Fphe%2Fabstract.00019053-200927050-00006.htm Page: 421DOI: 10.2165/00019053-200927050-00006Authors: Itani, Kamal M.F. 1; Akhras, Kasem S. 2; Stellhorn, Robert 2; Quintana, Alvaro 2; Budd, David 2; Merchant, Sanjay 2 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2587223 Fri, 10 Jul 2009 11:58:01 +0100 2587223 Utility Assessment in Patients with Mental Disorders: Validity and Discriminative Ability of the Time Trade-Off Method. http://www.medworm.com/index.php?rid=2587222&cid=s_33940_51_f&fid=34367&url=http%3A%2F%2Fpharmacoeconomics.adisonline.com%2Fpt%2Fre%2Fphe%2Fabstract.00019053-200927050-00005.htm Page: 405DOI: 10.2165/00019053-200927050-00005Authors: Konig, Hans-Helmut 1; Gunther, Oliver H. 1; Angermeyer, Matthias C. 2; Roick, Christiane 1 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2587222 Fri, 10 Jul 2009 11:58:01 +0100 2587222 The Cost of Dementia in Europe: A Review of the Evidence, and Methodological Considerations. http://www.medworm.com/index.php?rid=2587221&cid=s_33940_51_f&fid=34367&url=http%3A%2F%2Fpharmacoeconomics.adisonline.com%2Fpt%2Fre%2Fphe%2Fabstract.00019053-200927050-00004.htm Supplemental Digital Content is available in the textPage: 391DOI: 10.2165/00019053-200927050-00004Authors: Jonsson, Linus 1; Wimo, Anders 2 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2587221 Fri, 10 Jul 2009 11:58:01 +0100 2587221 Costing Infectious Disease Outbreaks for Economic Evaluation: A Review for Hepatitis A. http://www.medworm.com/index.php?rid=2587220&cid=s_33940_51_f&fid=34367&url=http%3A%2F%2Fpharmacoeconomics.adisonline.com%2Fpt%2Fre%2Fphe%2Fabstract.00019053-200927050-00003.htm Page: 379DOI: 10.2165/00019053-200927050-00003Authors: Luyten, Jeroen; Beutels, Philippe (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2587220 Fri, 10 Jul 2009 11:58:01 +0100 2587220 The Cost and Impact of Health Conditions on Presenteeism to Employers: A Review of the Literature. http://www.medworm.com/index.php?rid=2587219&cid=s_33940_51_f&fid=34367&url=http%3A%2F%2Fpharmacoeconomics.adisonline.com%2Fpt%2Fre%2Fphe%2Fabstract.00019053-200927050-00002.htm Page: 365DOI: 10.2165/00019053-200927050-00002Authors: Schultz, Alyssa B.; Chen, Chin-Yu; Edington, Dee W. (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2587219 Fri, 10 Jul 2009 11:58:01 +0100 2587219 The Future Costs, Risks and Rewards of Drug Development: The Economics of Pharmacogenomics. http://www.medworm.com/index.php?rid=2587218&cid=s_33940_51_f&fid=34367&url=http%3A%2F%2Fpharmacoeconomics.adisonline.com%2Fpt%2Fre%2Fphe%2Fabstract.00019053-200927050-00001.htm Page: 355DOI: 10.2165/00019053-200927050-00001Authors: Cook, Joseph 1; Hunter, Graeme 2; Vernon, John A. 3 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2587218 Thu, 09 Jul 2009 23:33:08 +0100 2587218 Clinical Effectiveness and Cost Effectiveness of Tailoring Chronic Hepatitis C Treatment with Peginterferon Alpha-2b Plus Ribavirin to HCV Genotype and Early Viral Response: A Decision Analysis Based on German Guidelines http://www.medworm.com/index.php?rid=2454699&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000004%2Fart00006 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2454699 Fri, 05 Jun 2009 20:29:45 +0100 2454699 Impact of Transdermal Oxybutynin on Work Productivity in Patients with Overactive Bladder: Results from the MATRIX Study http://www.medworm.com/index.php?rid=2454698&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000004%2Fart00005 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2454698 Fri, 05 Jun 2009 20:29:45 +0100 2454698 Cost Effectiveness of Drug-Eluting Stents In Belgian Practice: Healthcare Payer Perspective http://www.medworm.com/index.php?rid=2454697&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000004%2Fart00004 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2454697 Fri, 05 Jun 2009 20:29:45 +0100 2454697 Willingness to Pay for Cancer Prevention http://www.medworm.com/index.php?rid=2454696&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000004%2Fart00003 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2454696 Fri, 05 Jun 2009 20:29:45 +0100 2454696 Reviewing the Cost Effectiveness of Rotavirus Vaccination: The Importance of Uncertainty in the Choice of Data Sources http://www.medworm.com/index.php?rid=2454695&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000004%2Fart00002 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2454695 Fri, 05 Jun 2009 20:29:45 +0100 2454695 Clinical Effectiveness and Cost Effectiveness of Tailoring Chronic Hepatitis C Treatment with Peginterferon Alpha-2b Plus Ribavirin to HCV Genotype and Early Viral Response: A Decision Analysis Based on German Guidelines. http://www.medworm.com/index.php?rid=2454644&cid=s_33940_51_f&fid=34367&url=http%3A%2F%2Fpharmacoeconomics.adisonline.com%2Fpt%2Fre%2Fphe%2Fabstract.00019053-200927040-00006.htm Page: 341DOI: 10.2165/00019053-200927040-00006Authors: Siebert, Uwe 1 2 3; Sroczynski, Gaby 1 2; Aidelsburger, Pamela 4; Rossol, Siegbert 5; Wasem, Jurgen 4; Manns, Michael P. 6; McHutchison, John G. 7; Wong, John B. 8 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2454644 Fri, 05 Jun 2009 20:28:09 +0100 2454644 Impact of Transdermal Oxybutynin on Work Productivity in Patients with Overactive Bladder: Results from the MATRIX Study. http://www.medworm.com/index.php?rid=2454643&cid=s_33940_51_f&fid=34367&url=http%3A%2F%2Fpharmacoeconomics.adisonline.com%2Fpt%2Fre%2Fphe%2Fabstract.00019053-200927040-00005.htm Page: 329DOI: 10.2165/00019053-200927040-00005Authors: Pizzi, Laura T. 1; Talati, Amy 2; Gemmen, Eric 3; Dahl, Naomi V. 4; Bunz, Thomas J. 1; Sand, Peter K. 5 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2454643 Fri, 05 Jun 2009 20:28:09 +0100 2454643 Cost Effectiveness of Drug-Eluting Stents In Belgian Practice: Healthcare Payer Perspective. http://www.medworm.com/index.php?rid=2454642&cid=s_33940_51_f&fid=34367&url=http%3A%2F%2Fpharmacoeconomics.adisonline.com%2Fpt%2Fre%2Fphe%2Fabstract.00019053-200927040-00004.htm Page: 313DOI: 10.2165/00019053-200927040-00004Authors: Neyt, Mattias 1; De Laet, Chris 1; De Ridder, Annemieke 2; Van Brabandt, Hans 1 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2454642 Fri, 05 Jun 2009 20:28:09 +0100 2454642 Willingness to Pay for Cancer Prevention. http://www.medworm.com/index.php?rid=2454641&cid=s_33940_51_f&fid=34367&url=http%3A%2F%2Fpharmacoeconomics.adisonline.com%2Fpt%2Fre%2Fphe%2Fabstract.00019053-200927040-00003.htm Page: 299DOI: 10.2165/00019053-200927040-00003Authors: Hunt, Timothy L. 1; Luce, Bryan R. 2; Page, Matthew J. 2; Pokrzywinski, Robin 2 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2454641 Fri, 05 Jun 2009 20:28:09 +0100 2454641 Reviewing the Cost Effectiveness of Rotavirus Vaccination: The Importance of Uncertainty in the Choice of Data Sources. http://www.medworm.com/index.php?rid=2454640&cid=s_33940_51_f&fid=34367&url=http%3A%2F%2Fpharmacoeconomics.adisonline.com%2Fpt%2Fre%2Fphe%2Fabstract.00019053-200927040-00002.htm Page: 281DOI: 10.2165/00019053-200927040-00002Authors: Bilcke, Joke 1; Beutels, Philippe 1 2 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2454640 Fri, 05 Jun 2009 20:28:09 +0100 2454640 Economic and Human Costs of Restless Legs Syndrome http://www.medworm.com/index.php?rid=2454694&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000004%2Fart00001 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2454694 Fri, 05 Jun 2009 02:05:59 +0100 2454694 Economic and Human Costs of Restless Legs Syndrome. http://www.medworm.com/index.php?rid=2454639&cid=s_33940_51_f&fid=34367&url=http%3A%2F%2Fpharmacoeconomics.adisonline.com%2Fpt%2Fre%2Fphe%2Fabstract.00019053-200927040-00001.htm Page: 267DOI: 10.2165/00019053-200927040-00001Authors: Reinhold, Thomas; Muller-Riemenschneider, Falk; Willich, Stefan N.; Bruggenjurgen, Bernd (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2454639 Thu, 04 Jun 2009 23:35:06 +0100 2454639 Methods of Economic Evaluation for the German Statutory Healthcare System http://www.medworm.com/index.php?rid=2338529&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000003%2Fart00009 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2338529 Sat, 18 Apr 2009 16:48:46 +0100 2338529 Methods of Economic Evaluation for the German Statutory Healthcare System http://www.medworm.com/index.php?rid=2338528&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000003%2Fart00008 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2338528 Sat, 18 Apr 2009 16:48:46 +0100 2338528 Cost-Utility Analysis of Varenicline, an Oral Smoking-Cessation Drug, in Japan http://www.medworm.com/index.php?rid=2338527&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000003%2Fart00007 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2338527 Sat, 18 Apr 2009 16:48:46 +0100 2338527 Cost-Effectiveness Evaluation of a Quadrivalent Human Papillomavirus Vaccine in Belgium http://www.medworm.com/index.php?rid=2338526&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000003%2Fart00006 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2338526 Sat, 18 Apr 2009 16:48:46 +0100 2338526 The Lifetime Cost Effectiveness of Amlodipine-Based Therapy Plus Atorvastatin Compared with Atenolol Plus Atorvastatin, Amlodipine-Based Therapy Alone and Atenolol-Based Therapy Alone: Results from ASCOT1 http://www.medworm.com/index.php?rid=2338525&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000003%2Fart00005 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2338525 Sat, 18 Apr 2009 16:48:46 +0100 2338525 Preferences of GPs and Patients for Preventive Osteoporosis Drug Treatment: A Discrete-Choice Experiment http://www.medworm.com/index.php?rid=2338524&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000003%2Fart00004 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2338524 Sat, 18 Apr 2009 16:48:46 +0100 2338524 The Costs of Treating Breast Cancer in the US: A Synthesis of Published Evidence http://www.medworm.com/index.php?rid=2338523&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000003%2Fart00003 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2338523 Sat, 18 Apr 2009 16:48:46 +0100 2338523 Cost of Illness of Glaucoma: A Critical and Systematic Review http://www.medworm.com/index.php?rid=2338522&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000003%2Fart00002 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2338522 Sat, 18 Apr 2009 16:48:46 +0100 2338522 Costing and Cost Analysis in Randomized Controlled Trials: Caveat Emptor http://www.medworm.com/index.php?rid=2338521&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000003%2Fart00001 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2338521 Sat, 18 Apr 2009 16:48:46 +0100 2338521 Methods of Economic Evaluation for the German Statutory Healthcare System. http://www.medworm.com/index.php?rid=2320958&cid=s_33940_51_f&fid=34367&url=http%3A%2F%2Fpharmacoeconomics.adisonline.com%2Fpt%2Fre%2Fphe%2Fabstract.00019053-200927030-00009.htm Page: 265DOI: 10.2165/00019053-200927030-00009Authors: Mittendorf, Thomas 1; Greiner, Wolfgang 2; von der Schulenburg, Johann-Matthias 1 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2320958 Fri, 10 Apr 2009 23:13:50 +0100 2320958 Methods of Economic Evaluation for the German Statutory Healthcare System. http://www.medworm.com/index.php?rid=2320955&cid=s_33940_51_f&fid=34367&url=http%3A%2F%2Fpharmacoeconomics.adisonline.com%2Fpt%2Fre%2Fphe%2Fabstract.00019053-200927030-00008.htm Page: 263DOI: 10.2165/00019053-200927030-00008Authors: Caro, J. Jaime (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2320955 Fri, 10 Apr 2009 23:13:50 +0100 2320955 Cost-Utility Analysis of Varenicline, an Oral Smoking-Cessation Drug, in Japan. http://www.medworm.com/index.php?rid=2320953&cid=s_33940_51_f&fid=34367&url=http%3A%2F%2Fpharmacoeconomics.adisonline.com%2Fpt%2Fre%2Fphe%2Fabstract.00019053-200927030-00007.htm Page: 247DOI: 10.2165/00019053-200927030-00007Authors: Igarashi, Ataru 1; Takuma, Hiroki 2; Fukuda, Takashi 3; Tsutani, Kiichiro 1 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2320953 Fri, 10 Apr 2009 23:13:50 +0100 2320953 Cost-Effectiveness Evaluation of a Quadrivalent Human Papillomavirus Vaccine in Belgium. http://www.medworm.com/index.php?rid=2320951&cid=s_33940_51_f&fid=34367&url=http%3A%2F%2Fpharmacoeconomics.adisonline.com%2Fpt%2Fre%2Fphe%2Fabstract.00019053-200927030-00006.htm Page: 231DOI: 10.2165/00019053-200927030-00006Authors: Annemans, Lieven 1; Remy, Vanessa 2; Oyee, James 3; Largeron, Nathalie 2 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2320951 Fri, 10 Apr 2009 23:13:50 +0100 2320951 The Lifetime Cost Effectiveness of Amlodipine-Based Therapy Plus Atorvastatin Compared with Atenolol Plus Atorvastatin, Amlodipine-Based Therapy Alone and Atenolol-Based Therapy Alone: Results from ASCOT 1. http://www.medworm.com/index.php?rid=2320948&cid=s_33940_51_f&fid=34367&url=http%3A%2F%2Fpharmacoeconomics.adisonline.com%2Fpt%2Fre%2Fphe%2Fabstract.00019053-200927030-00005.htm Page: 221DOI: 10.2165/00019053-200927030-00005Authors: Lindgren, Peter 1 2; Buxton, Martin 3; Kahan, Thomas 4; Poulter, Neil R. 5; Dahlof, Bjorn 6; Sever, Peter S. 5; Wedel, Hans 7; Jonsson, Bengt 8; on behalf of the ASCOT investigators (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2320948 Fri, 10 Apr 2009 23:13:50 +0100 2320948 Preferences of GPs and Patients for Preventive Osteoporosis Drug Treatment: A Discrete-Choice Experiment. http://www.medworm.com/index.php?rid=2320946&cid=s_33940_51_f&fid=34367&url=http%3A%2F%2Fpharmacoeconomics.adisonline.com%2Fpt%2Fre%2Fphe%2Fabstract.00019053-200927030-00004.htm Page: 211DOI: 10.2165/00019053-200927030-00004Authors: de Bekker-Grob, Esther W. 1; Essink-Bot, Marie-Louise 1 2; Meerding, Willem Jan 1; Koes, Bart W. 3; Steyerberg, Ewout W. 1 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2320946 Fri, 10 Apr 2009 23:13:50 +0100 2320946 The Costs of Treating Breast Cancer in the US: A Synthesis of Published Evidence. http://www.medworm.com/index.php?rid=2320943&cid=s_33940_51_f&fid=34367&url=http%3A%2F%2Fpharmacoeconomics.adisonline.com%2Fpt%2Fre%2Fphe%2Fabstract.00019053-200927030-00003.htm Page: 199DOI: 10.2165/00019053-200927030-00003Authors: Campbell, Jonathan D. 1 2; Ramsey, Scott D. 1 2 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2320943 Fri, 10 Apr 2009 23:13:50 +0100 2320943 Cost of Illness of Glaucoma: A Critical and Systematic Review. http://www.medworm.com/index.php?rid=2320942&cid=s_33940_51_f&fid=34367&url=http%3A%2F%2Fpharmacoeconomics.adisonline.com%2Fpt%2Fre%2Fphe%2Fabstract.00019053-200927030-00002.htm Page: 189DOI: 10.2165/00019053-200927030-00002Authors: Fiscella, Richard G. 1; Lee, Jeff 2; Davis, Elizabeth J.H. 2; Walt, John 2 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2320942 Fri, 10 Apr 2009 23:13:50 +0100 2320942 Costing and Cost Analysis in Randomized Controlled Trials: Caveat Emptor. http://www.medworm.com/index.php?rid=2320941&cid=s_33940_51_f&fid=34367&url=http%3A%2F%2Fpharmacoeconomics.adisonline.com%2Fpt%2Fre%2Fphe%2Fabstract.00019053-200927030-00001.htm Page: 179DOI: 10.2165/00019053-200927030-00001Authors: Polsky, Daniel; Glick, Henry (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2320941 Thu, 09 Apr 2009 23:33:23 +0100 2320941 Challenges in Merging Medicaid and Medicare Databases to Obtain Healthcare Costs for Dual-Eligible Beneficiaries: Using Diabetes as an Example. http://www.medworm.com/index.php?rid=2232049&cid=s_33940_51_f&fid=34367&url=http%3A%2F%2Fpharmacoeconomics.adisonline.com%2Fpt%2Fre%2Fphe%2Fabstract.00019053-200927020-00007.htm Page: 167DOI: 10.2165/00019053-200927020-00007Authors: Prela, Cecilia M. 1; Baumgardner, Greg A. 2; Reiber, Gayle E. 3; McFarland, Lynne V. 3; Maynard, Charles 3; Anderson, Nancy 4; Maciejewski, Matthew 5 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2232049 Wed, 04 Mar 2009 20:37:27 +0100 2232049 Comparison of Markov Model and Discrete-Event Simulation Techniques for HIV. http://www.medworm.com/index.php?rid=2232048&cid=s_33940_51_f&fid=34367&url=http%3A%2F%2Fpharmacoeconomics.adisonline.com%2Fpt%2Fre%2Fphe%2Fabstract.00019053-200927020-00006.htm Page: 159DOI: 10.2165/00019053-200927020-00006Authors: Simpson, Kit N. 1; Strassburger, Alvin 1; Jones, Walter J. 1; Dietz, Birgitta 2; Rajagopalan, Rukmini 3 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2232048 Wed, 04 Mar 2009 20:37:27 +0100 2232048 Willingness to Pay for a Treatment for Pain in Multiple Sclerosis. http://www.medworm.com/index.php?rid=2232047&cid=s_33940_51_f&fid=34367&url=http%3A%2F%2Fpharmacoeconomics.adisonline.com%2Fpt%2Fre%2Fphe%2Fabstract.00019053-200927020-00005.htm Page: 149DOI: 10.2165/00019053-200927020-00005Authors: Iskedjian, Michael 1 2; Desjardins, Olivier 1; Piwko, Charles 1; Bereza, Basil 1; Jaszewski, Barbara 3; Einarson, Thomas R. 1 4 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2232047 Wed, 04 Mar 2009 20:37:27 +0100 2232047 Effectiveness and Cost Effectiveness of Human Papillomavirus Vaccine: A Systematic Review. http://www.medworm.com/index.php?rid=2232046&cid=s_33940_51_f&fid=34367&url=http%3A%2F%2Fpharmacoeconomics.adisonline.com%2Fpt%2Fre%2Fphe%2Fabstract.00019053-200927020-00004.htm Page: 127DOI: 10.2165/00019053-200927020-00004Authors: Marra, Fawziah 1 2; Cloutier, Karine 3; Oteng, Bridgette 1; Marra, Carlo 1 4; Ogilvie, Gina 1 2 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2232046 Wed, 04 Mar 2009 20:37:27 +0100 2232046 Economics of Treatments for Non-Small Cell Lung Cancer. http://www.medworm.com/index.php?rid=2232045&cid=s_33940_51_f&fid=34367&url=http%3A%2F%2Fpharmacoeconomics.adisonline.com%2Fpt%2Fre%2Fphe%2Fabstract.00019053-200927020-00003.htm Page: 113DOI: 10.2165/00019053-200927020-00003Authors: Chouaid, Christos 1 2 3; Atsou, Kukovi 1; Hejblum, Gilles 1 4; Vergnenegre, Alain 5 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2232045 Wed, 04 Mar 2009 20:37:27 +0100 2232045 Neuropathic Pain: Quality-of-Life Impact, Costs and Cost Effectiveness of Therapy. http://www.medworm.com/index.php?rid=2232044&cid=s_33940_51_f&fid=34367&url=http%3A%2F%2Fpharmacoeconomics.adisonline.com%2Fpt%2Fre%2Fphe%2Fabstract.00019053-200927020-00002.htm Page: 95DOI: 10.2165/00019053-200927020-00002Authors: O'Connor, Alec B. (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2232044 Wed, 04 Mar 2009 20:37:27 +0100 2232044 Controlling Cervical Cancer. http://www.medworm.com/index.php?rid=2232043&cid=s_33940_51_f&fid=34367&url=http%3A%2F%2Fpharmacoeconomics.adisonline.com%2Fpt%2Fre%2Fphe%2Fabstract.00019053-200927020-00001.htm Page: 91DOI: 10.2165/00019053-200927020-00001Authors: Bonati, Maurizio 1; Garattini, Silvio 2 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2232043 Wed, 04 Mar 2009 17:34:31 +0100 2232043 Challenges in Merging Medicaid and Medicare Databases to Obtain Healthcare Costs for Dual-Eligible Beneficiaries: Using Diabetes as an Example http://www.medworm.com/index.php?rid=2230787&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000002%2Fart00007 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2230787 Wed, 04 Mar 2009 14:08:24 +0100 2230787 Comparison of Markov Model and Discrete-Event Simulation Techniques for HIV http://www.medworm.com/index.php?rid=2230786&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000002%2Fart00006 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2230786 Wed, 04 Mar 2009 14:08:24 +0100 2230786 Willingness to Pay for a Treatment for Pain in Multiple Sclerosis http://www.medworm.com/index.php?rid=2230785&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000002%2Fart00005 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2230785 Wed, 04 Mar 2009 14:08:24 +0100 2230785 Effectiveness and Cost Effectiveness of Human Papillomavirus Vaccine: A Systematic Review http://www.medworm.com/index.php?rid=2230784&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000002%2Fart00004 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2230784 Wed, 04 Mar 2009 14:08:24 +0100 2230784 Economics of Treatments for Non-Small Cell Lung Cancer http://www.medworm.com/index.php?rid=2230783&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000002%2Fart00003 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2230783 Wed, 04 Mar 2009 14:08:24 +0100 2230783 Neuropathic Pain: Quality-of-Life Impact, Costs and Cost Effectiveness of Therapy http://www.medworm.com/index.php?rid=2230782&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000002%2Fart00002 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2230782 Wed, 04 Mar 2009 14:08:24 +0100 2230782 Controlling Cervical Cancer http://www.medworm.com/index.php?rid=2230781&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2009%2F00000027%2F00000002%2Fart00001 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2230781 Wed, 04 Mar 2009 14:08:24 +0100 2230781 Estimating the Cost of Diabetes Mellitus-Related Events from Inpatient Admissions in Sweden Using Administrative Hospitalization Data. http://www.medworm.com/index.php?rid=2152786&cid=s_33940_51_f&fid=34367&url=http%3A%2F%2Fpharmacoeconomics.adisonline.com%2Fpt%2Fre%2Fphe%2Fabstract.00019053-200927010-00008.htm Page: 81DOI: 10.2165/00019053-200927010-00008Authors: Gerdtham, Ulf-G 1 2 3; Clarke, Philip 4; Hayes, Alison 4; Gudbjornsdottir, Soffia 5 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2152786 Tue, 03 Feb 2009 07:28:51 +0100 2152786 Comparing the Cost Effectiveness of Risperidone and Olanzapine in the Treatment of Schizophrenia Using the Net-Benefit Regression Approach. http://www.medworm.com/index.php?rid=2152785&cid=s_33940_51_f&fid=34367&url=http%3A%2F%2Fpharmacoeconomics.adisonline.com%2Fpt%2Fre%2Fphe%2Fabstract.00019053-200927010-00007.htm Page: 69DOI: 10.2165/00019053-200927010-00007Authors: De Ridder, Annemieke; De Graeve, Diana (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2152785 Tue, 03 Feb 2009 07:28:51 +0100 2152785 Cost Effectiveness of High-Dose Chemotherapy with Autologous Stem Cell Support as Initial Treatment of Aggressive Non-Hodgkin's Lymphoma. http://www.medworm.com/index.php?rid=2152784&cid=s_33940_51_f&fid=34367&url=http%3A%2F%2Fpharmacoeconomics.adisonline.com%2Fpt%2Fre%2Fphe%2Fabstract.00019053-200927010-00006.htm Page: 55DOI: 10.2165/00019053-200927010-00006Authors: Fagnoni, Philippe 1 2; Milpied, Noel 3; Limat, Samuel 1 2; Deconinck, Eric 4 5; Nerich, Virginie 1 4; Foussard, Charles 6; Colombat, Philippe 7; Harousseau, Jean-Luc 8; Woronoff-Lemsi, Marie-Christine 1 4; for the Groupe Ouest-Est des Leucemies et des Autres Maladies du Sang (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2152784 Tue, 03 Feb 2009 07:28:51 +0100 2152784 Treating Relapsing Multiple Sclerosis with Subcutaneous versus Intramuscular Interferon-Beta-1a: Modelling the Clinical and Economic Implications. http://www.medworm.com/index.php?rid=2152783&cid=s_33940_51_f&fid=34367&url=http%3A%2F%2Fpharmacoeconomics.adisonline.com%2Fpt%2Fre%2Fphe%2Fabstract.00019053-200927010-00005.htm Page: 39DOI: 10.2165/00019053-200927010-00005Authors: Guo, Shien 1 2; Bozkaya, Duygu 1; Ward, Alexandra 1; O'Brien, Judith A. 1; Ishak, Khajak 3; Bennett, Randy 4; Al-Sabbagh, Ahmad 4; Meletiche, Dennis M. 4 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2152783 Tue, 03 Feb 2009 07:28:51 +0100 2152783 Statin Therapy in Rheumatoid Arthritis: A Cost-Effectiveness and Value-of-Information Analysis. http://www.medworm.com/index.php?rid=2152782&cid=s_33940_51_f&fid=34367&url=http%3A%2F%2Fpharmacoeconomics.adisonline.com%2Fpt%2Fre%2Fphe%2Fabstract.00019053-200927010-00004.htm Page: 25DOI: 10.2165/00019053-200927010-00004Authors: Bansback, Nick 1 2; Ara, Roberta 2; Ward, Sue 2; Anis, Aslam 1 3; Choi, Hyon K. 3 4 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2152782 Tue, 03 Feb 2009 07:28:51 +0100 2152782 Is Medication Review by Primary-Care Pharmacists for Older People Cost Effective?: A Narrative Review of the Literature, Focusing on Costs and Benefits. http://www.medworm.com/index.php?rid=2152781&cid=s_33940_51_f&fid=34367&url=http%3A%2F%2Fpharmacoeconomics.adisonline.com%2Fpt%2Fre%2Fphe%2Fabstract.00019053-200927010-00003.htm Page: 11DOI: 10.2165/00019053-200927010-00003Authors: Zermansky, Arnold G.; Silcock, Jonathan (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2152781 Tue, 03 Feb 2009 07:28:51 +0100 2152781 The Applicability and Generalizability of Findings from Clinical Trials for Health-Policy Decisions. http://www.medworm.com/index.php?rid=2152780&cid=s_33940_51_f&fid=34367&url=http%3A%2F%2Fpharmacoeconomics.adisonline.com%2Fpt%2Fre%2Fphe%2Fabstract.00019053-200927010-00002.htm Page: 5DOI: 10.2165/00019053-200927010-00002Authors: Freemantle, Nick 1; Hessel, Franz 2 3 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2152780 Tue, 03 Feb 2009 07:28:51 +0100 2152780 Methods of Economic Evaluation for the German Statutory Healthcare System. http://www.medworm.com/index.php?rid=2152779&cid=s_33940_51_f&fid=34367&url=http%3A%2F%2Fpharmacoeconomics.adisonline.com%2Fpt%2Fre%2Fphe%2Fabstract.00019053-200927010-00001.htm Page: 1DOI: 10.2165/00019053-200927010-00001Authors: Dong, Hengjin (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=2152779 Tue, 03 Feb 2009 01:51:25 +0100 2152779